Clinical Trials Browser

Phase 3 × Completed × Immune System Diseases × Clear all

NCT00773747 2021-04-30

Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT00000591 2016-04-15

T-Cell Depletion in Unrelated Donor Marrow Transplantation

Phase 3 Completed

MyeloidOther hematologic neoplasm

Graft vs Host Disease, Immune System Diseases, Leukemia, Myelodysplastic Syndromes